Get ready for an earful on embryonic stem cell research as the World Stem Cell Summit rolls into Detroit. More than 1,200 people are expected to gather for the Oct. 4-6 conference. It is to focus on adult and embryonic stem cell research and other regenerative medical issues. Sponsors say the timing is perfect with the national debate on embryonic stem cell research playing out in a federal court and Congress. At issue: what research to allow and what should be the federal government’s role in subsidizing it. The controversy is over embryonic stem cell research.
Recent Posts
- Infant becomes world’s first patient to undergo personalized gene-editing treatment
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise
- New Cell Therapy For Resistant Hodgkins Patients